Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

  • This share is currently suspended. It was suspended at a price of 398.00
  • There is currently no data for TYMN

Director/PDMR Shareholding

24 Apr 2024 17:09

RNS Number : 9199L
Tyman PLC
24 April 2024
 

TYMAN PLC

("Tyman" or the "Company" or the "Group")

 

DIRECTOR/PDMR SHAREHOLDINGS

 

Tyman plc announces that it has been notified of the following transactions in the Company's ordinary 5p shares ("Shares") undertaken by the Executive Directors and PDMRs, Rutger Helbing, CEO and Jason Ashton, CFO.

 

LONG TERM INCENTIVE PLAN (THE "LTIP")

Following the end of a closed period, the following awards over Shares were awarded under the Company's LTIP, in the form of nil cost options (the "2024 LTIP Awards"):

Name

Shares awarded1

Rutger Helbing

314,575

Jason Ashton

214,959

1 Number of shares calculated by reference to the 5-day average closing price prior to the date that shares were awarded (5 trading days ended 13th March 2024) of £2.861.

 

Vesting conditions in respect of the 2024 LTIP Awards

 

The vesting of the 2024 LTIP Awards is subject to the satisfaction of performance conditions set by the Remuneration Committee of the Company, as disclosed in the 2023 Annual Report and Accounts, published on 28 March 2024. 2024 LTIP Awards have a three-year vesting period. 2024 LTIP Awards are normally subject to continued employment. 2024 LTIP Awards granted to the Executive Directors that vest shall be subject to a compulsory holding period of five years from the "Award Date" of 14 March 2024. 

 

Impact of the recommended offer for the Company

On 22 April 2024, the boards of Quanex Building Products Corporation ("Quanex") and Tyman announced (the "2.7 Announcement") that they reached agreement on the terms of a recommended cash and share offer, pursuant to which Quanex will acquire the entire issued and to be issued ordinary share capital of Tyman (the "Transaction"). In this section, all capitalised terms used shall have the same meaning as in the 2.7 Announcement and the Cooperation Agreement for the Scheme, as agreed between Tyman and Quanex, unless expressly defined otherwise.

Pursuant to the terms agreed by Quanex and Tyman, the 2024 LTIP Awards were granted subject to additional terms that: (i) notwithstanding rules 12.1 and 12.2 of the LTIP rules, the 2024 LTIP Awards will not vest early on the Court Sanction Date; and (ii) the 2024 LTIP Awards will automatically lapse on the Effective Date if the Effective Date occurs prior to the Normal Vesting Date (as defined in the LTIP rules and to occur in March 2027) of such 2024 LTIP Awards.

On the lapsing of the 2024 LTIP Awards, due to the additional terms referred to in the paragraph above, and the occurrence of the Effective Date, Quanex agreed that, as soon as reasonably practicable after the Effective Date, Quanex shall grant to all individuals who:

(a) are Tyman Employees immediately prior to the Effective Date and who have not given or received notice of termination of employment prior to that time; and

(b) held outstanding 2024 LTIP Awards immediately prior to the Effective Date,

 

(each a "Replacement Award Participant") an award under the Quanex Omnibus Incentive Plan (the "Replacement Awards"). The Replacement Awards will be granted pursuant to those terms set out in the Cooperation Agreement which can be found here: https://www.tymanplc.com/investor-relations/recommended-offer-for-tyman-by-quanex.

 

Timetable and Awards Outstanding

 

The details of the Awards are set out below:

1

 

Details of the persons discharging managerial responsibilities / person closely associated

 

a)

 

Names

 

i. RUTGER HELBING

ii. JASON ASHTON

 

2

 

Reason for the notification: AWARD OF OPTIONS

 

a)

 

Position/status

 

i. CHIEF EXECUTIVE OFFICER

ii. CHIEF FINANCIAL OFFICER

 

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

TYMAN PLC

b)

 

LEI

 

213800AAFUV5PKGQU848

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

ORDINARY SHARES OF 5P EACH

 

Identification code

ISIN NUMBER:GB00B29H4253

b)

 

Nature of the transaction

NIL COST OPTIONS GRANTED SUBJECT TO PERFORMANCE CONDITIONS UNDER TYMAN PLC LONG TERM INCENTIVE PLAN

c)

Prices (s) and volume(s)

Price

Volume

i.

Nil

314,575

ii.

Nil

214,959

d)

 

Aggregated information

- Aggregated volume

- 529,534

 

- Price

- Nil

e)

 

Date of the transaction

 

14 March 2024

f)

 

Place of the transaction

OUTSIDE OF TRADING VENUE

 

This disclosure is made in accordance with Article 19 of EU Market Abuse Regulation No. 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

 

 

24 April 2024

 

 

 

Enquiries:

Tyman plc

020 7976 8000

Peter Ho - General Counsel & Company Secretary

www.tymanplc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQZLFLZZLBBBD
Date   Source Headline
23rd Apr 202411:53 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:45 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:41 amPRNForm 8.3 - Tyman plc
23rd Apr 202411:35 amRNSForm 8.5 (EPT/RI) - Tyman Plc
23rd Apr 202411:32 amRNSForm 8.3 -Quanex Building Products Corporation
23rd Apr 202411:29 amRNSForm 8.3 - Tyman plc
23rd Apr 202410:49 amRNSForm 8.5 (EPT/RI) - Tyman Plc
22nd Apr 20242:59 pmRNSForm 8.3 - Quanex Building Products Corporation
22nd Apr 20242:57 pmRNSForm 8.3 - Tyman plc
22nd Apr 202412:01 pmPRNForm 8.3 - Tyman plc
22nd Apr 20247:00 amRNSRecommended Cash and Share Offer
17th Apr 202411:22 amRNSHolding(s) in Company
28th Mar 20247:00 amRNS2023 Annual Report & Notice of AGM
7th Mar 20247:00 amRNSFinal Results
31st Jan 20247:00 amRNSNotice of Results
10th Jan 20248:00 amRNSDirector Declaration
27th Nov 20236:17 pmRNSDirector/PDMR Shareholding
27th Nov 20237:00 amRNSAppointment of new CEO
20th Nov 20232:00 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTrading Statement
31st Oct 20237:00 amRNSCapital Markets Event
2nd Oct 20237:00 amRNSNotice of Capital Markets Event
25th Jul 20237:00 amRNSHalf-year Report
12th Jul 20235:00 pmRNSAcquisition of Lawrence Industries
8th Jun 20239:21 amRNSHolding(s) in Company
1st Jun 20237:00 amRNSSBTi approval of carbon reduction targets
31st May 20237:00 amRNSDirectorate Changes
26th May 202310:59 amRNSDirector/PDMR Shareholding
19th May 202310:24 amRNSDirector/PDMR Shareholding
18th May 20231:30 pmRNSResult of AGM
18th May 20237:00 amRNSAGM Trading Update
21st Apr 20237:00 amRNSAppointment of Interim Chief Financial Officer
21st Apr 20237:00 amRNSDirector/PDMR Shareholding
6th Apr 20233:10 pmRNSAGM Update - Withdrawal of AGM Resolution
6th Apr 20237:00 amRNSDirectorate Change
3rd Apr 20237:00 amRNSAnnual Financial Report
30th Mar 20239:10 amRNSDirector/PDMR Shareholding
24th Mar 20231:34 pmRNSHolding(s) in Company
22nd Mar 20234:30 pmRNSDirector/PDMR Shareholding
14th Mar 20234:16 pmRNSDirector/PDMR Shareholding
3rd Mar 20235:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNotice of Results
28th Dec 20223:53 pmRNSHolding(s) in Company
15th Dec 202210:59 amRNSHolding(s) in Company
14th Dec 202212:00 pmRNSRefinancing of Debt Facilities
28th Nov 20223:30 pmRNSHolding(s) in Company
17th Nov 20227:00 amRNSTrading Statement
18th Oct 202212:00 pmRNSHolding(s) in Company
6th Oct 20223:41 pmRNSTR-1 Replacement: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.